Owens & Minor (OMI) versus The Competition Critical Survey

Owens & Minor (NYSE:OMI) is one of 143 publicly-traded companies in the “MED PRODUCTS” industry, but how does it weigh in compared to its peers? We will compare Owens & Minor to related businesses based on the strength of its earnings, risk, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of recent recommendations for Owens & Minor and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owens & Minor	1	2	2	0	2.20
Owens & Minor Competitors	766	3720	7526	286	2.60

Owens & Minor presently has a consensus target price of $11.60, suggesting a potential upside of 49.29%. As a group, “MED PRODUCTS” companies have a potential upside of 43.37%. Given Owens & Minor’s higher probable upside, equities analysts clearly believe Owens & Minor is more favorable than its peers.

Profitability

This table compares Owens & Minor and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Owens & Minor	-3.41%	17.09%	2.47%
Owens & Minor Competitors	-26.13%	-30.13%	-6.94%

Valuation and Earnings

This table compares Owens & Minor and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Owens & Minor	$10.72 billion	-$362.69 million	-1.64
Owens & Minor Competitors	$2.81 billion	$246.14 million	4.17

Owens & Minor has higher revenue, but lower earnings than its peers. Owens & Minor is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 44.7% of shares of all “MED PRODUCTS” companies are owned by institutional investors. 3.7% of Owens & Minor shares are owned by company insiders. Comparatively, 12.3% of shares of all “MED PRODUCTS” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Volatility and Risk

Owens & Minor has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. Comparatively, Owens & Minor’s peers have a beta of 11.24, indicating that their average share price is 1,024% more volatile than the S&P 500.

Summary

Owens & Minor peers beat Owens & Minor on 7 of the 13 factors compared.

About Owens & Minor

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.